Science5 hours ago
Ionis Pharmaceuticals to Present Key Data on Olezarsen at AHA
Ionis Pharmaceuticals, Inc. announced that it will present detailed findings from its pivotal Phase 3 CORE and CORE2 studies of olezarsen during a late-breaking session at...